Clinical Trial Update: Trial of Pancreatic Enzyme Supplements (Pancrelipase) for Treating Pain in Patients With Chronic Pancreatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pancreatic enzyme supplements (pancrelipase) for pain in chronic pancreatitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis

Drugs mentioned

• Pancrelipase (pancrelipase)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Pancreatitis | Phase 2 | Status: WITHDRAWN